{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T04:44:14Z","timestamp":1776401054879,"version":"3.51.2"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T00:00:00Z","timestamp":1400198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1007\/s10549-014-2990-y","type":"journal-article","created":{"date-parts":[[2014,5,15]],"date-time":"2014-05-15T15:51:44Z","timestamp":1400169104000},"page":"647-661","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Expression of membrane transporters and metabolic enzymes involved in estrone-3-sulphate disposition in human breast tumour tissues"],"prefix":"10.1007","volume":"145","author":[{"given":"Nilasha","family":"Banerjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Allen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reina","family":"Bendayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,16]]},"reference":[{"key":"2990_CR1","unstructured":"National Cancer Institute Annual Report (2013) http:\/\/seer.cancer.gov\/statfacts\/html\/breast.html"},{"key":"2990_CR2","author":"PM Ravdin","year":"2007","unstructured":"Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. doi: 10.1056\/NEJMsr070105","journal-title":"N Engl J Med"},{"key":"2990_CR3","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2967\/jnumed.110.078329","volume":"51","author":"HM Linden","year":"2010","unstructured":"Linden HM, Mankoff DA (2010) Breast cancer and hormonal stimulation: is glycolysis the first sign of response? J Nucl Med 51:1663\u20131664. doi: 10.2967\/jnumed.110.078329","journal-title":"J Nucl Med"},{"key":"2990_CR4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1023\/A:1020299707510","volume":"76","author":"WF Anderson","year":"2002","unstructured":"Anderson WF, Chatterjee N, Ershler WB, Brawley OW (2002) Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database. Breast Cancer Res Treat 76:27\u201336","journal-title":"Breast Cancer Res Treat"},{"key":"2990_CR5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jsbmb.2005.02.007","volume":"93","author":"JR Pasqualini","year":"2005","unstructured":"Pasqualini JR, Chetrite GS (2005) Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer. J Steroid Biochem Mol Biol 93:221\u2013236. doi: 10.1016\/j.jsbmb.2005.02.007","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2990_CR6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0960-0760(03)00364-9","volume":"86","author":"J Geisler","year":"2003","unstructured":"Geisler J (2003) Breast cancer tissue estrogens and their manipulation with aromatase inhibitors and inactivators. J Steroid Biochem Mol Biol 86:245\u2013253","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2990_CR7","first-page":"2900","volume":"45","author":"AA Landeghem Van","year":"1985","unstructured":"Van Landeghem AA, Poortman J, Nabuurs M, Thijssen JH (1985) Endogenous concentration and subcellular distribution of estrogens in normal and malignant human breast tissue. Cancer Res 45:2900\u20132906","journal-title":"Cancer Res"},{"key":"2990_CR8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jsbmb.2006.07.011","volume":"103","author":"A Kendall","year":"2007","unstructured":"Kendall A, Folkerd EJ, Dowsett M (2007) Influences on circulating oestrogens in postmenopausal women: relationship with breast cancer. J Steroid Biochem Mol Biol 103:99\u2013109","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2990_CR9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF01886734","volume":"7","author":"SJ Santner","year":"1986","unstructured":"Santner SJ, Leszczynski D, Wright C, Manni A, Feil PD, Santen RJ (1986) Estrone sulfate: a potential source of estradiol in human breast cancer tissues. Breast Cancer Res Treat 7:35\u201344","journal-title":"Breast Cancer Res Treat"},{"key":"2990_CR10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0960-0760(00)00040-6","volume":"72","author":"GS Chetrite","year":"2000","unstructured":"Chetrite GS, Cortes-Prieto J, Philippe JC, Wright F, Pasqualini JR (2000) Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues. J Steroid Biochem Mol Biol 72:23\u201327","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2990_CR11","first-page":"1460","volume":"81","author":"JR Pasqualini","year":"1996","unstructured":"Pasqualini JR, Chetrite G, Blacker C, Feinstein MC, Delalonde L, Talbi M, Maloche C (1996) Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients. J Clin Endocrinol Metab 81:1460\u20131464","journal-title":"J Clin Endocrinol Metab"},{"key":"2990_CR12","doi-asserted-by":"crossref","first-page":"863539","DOI":"10.1155\/2013\/863539","volume":"2013","author":"V Buxhofer-Ausch","year":"2013","unstructured":"Buxhofer-Ausch V, Secky L, Wlcek K, Svoboda M, Kounnis V, Briasoulis E, Tzakos AG, Jaeger W, Thalhammer T (2013) Tumor-specific expression of organic anion-transporting polypeptides: transporters as novel targets for cancer therapy. J Drug Deliv 2013:863539. doi: 10.1155\/2013\/863539","journal-title":"J Drug Deliv"},{"key":"2990_CR13","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.112.192344","volume":"342","author":"N Banerjee","year":"2012","unstructured":"Banerjee N, Allen C, Bendayan R (2012) Differential role of organic anion-transporting polypeptides in estrone-3-sulphate uptake by breast epithelial cells and breast cancer cells. J Pharmacol Exp Ther 342:510\u2013519. doi: 10.1124\/jpet.112.192344","journal-title":"J Pharmacol Exp Ther"},{"key":"2990_CR14","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","volume":"447","author":"B Hagenbuch","year":"2004","unstructured":"Hagenbuch B, Meier PJ (2004) Organic anion transporting polypeptides of the OATP\/SLC21 family: phylogenetic classification as OATP\/SLCO superfamily, new nomenclature and molecular\/functional properties. Pflugers Arch 447:653\u2013665","journal-title":"Pflugers Arch"},{"key":"2990_CR15","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1158\/0008-5472.CAN-05-1070","volume":"66","author":"Y Miki","year":"2006","unstructured":"Miki Y, Suzuki T, Kitada K, Yabuki N, Shibuya R, Moriya T, Ishida T, Ohuchi N, Blumberg B, Sasano H (2006) Expression of the steroid and xenobiotic receptor and its possible target gene, organic anion transporting polypeptide-A, in human breast carcinoma. Cancer Res 66:535\u2013542","journal-title":"Cancer Res"},{"key":"2990_CR16","doi-asserted-by":"crossref","first-page":"9338","DOI":"10.1158\/0008-5472.CAN-08-0265","volume":"68","author":"Zu Meyer","year":"2008","unstructured":"Meyer Zu, Schwabedissen HE, Tirona RG, Yip CS, Ho RH, Kim RB (2008) Interplay between the nuclear receptor pregnane X receptor and the uptake transporter organic anion transporter polypeptide 1A2 selectively enhances estrogen effects in breast cancer. Cancer Res 68:9338\u20139347","journal-title":"Cancer Res"},{"key":"2990_CR17","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1210\/jc.2003-030174","volume":"88","author":"F Pizzagalli","year":"2003","unstructured":"Pizzagalli F, Varga Z, Huber RD, Folkers G, Meier PJ, St-Pierre MV (2003) Identification of steroid sulfate transport processes in the human mammary gland. J Clin Endocrinol Metab 88:3902\u20133912","journal-title":"J Clin Endocrinol Metab"},{"key":"2990_CR18","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4161\/cbt.11.6.14533","volume":"11","author":"J Kindla","year":"2011","unstructured":"Kindla J, Rau TT, Jung R, Fasching PA, Strick R, Stoehr R, Hartmann A, Fromm MF, Konig J (2011) Expression and localization of the uptake transporters OATP2B1, OATP3A1 and OATP5A1 in non-malignant and malignant breast tissue. Cancer Biol Ther 11:584\u2013591","journal-title":"Cancer Biol Ther"},{"key":"2990_CR19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0960-0760(95)00116-H","volume":"53","author":"JR Pasqualini","year":"1995","unstructured":"Pasqualini JR, Chetrite G, Nguyen BL, Maloche C, Delalonde L, Talbi M, Feinstein MC, Blacker C, Botella J, Paris J (1995) Estrone sulfate-sulfatase and 17 beta-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependence to hormone-independence. J Steroid Biochem Mol Biol 53:407\u2013412","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2990_CR20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00008571-200206000-00008","volume":"12","author":"S Conrad","year":"2002","unstructured":"Conrad S, Kauffmann HM, Ito K, Leslie EM, Deeley RG, Schrenk D, Cole SP (2002) A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance. Pharmacogenetics 12:321\u2013330","journal-title":"Pharmacogenetics"},{"key":"2990_CR21","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1124\/mol.64.3.610","volume":"64","author":"Y Imai","year":"2003","unstructured":"Imai Y, Asada S, Tsukahara S, Ishikawa E, Tsuruo T, Sugimoto Y (2003) Breast cancer resistance protein exports sulfated estrogens but not free estrogens. Mol Pharmacol 64:610\u2013618. doi: 10.1124\/64.3.610","journal-title":"Mol Pharmacol"},{"key":"2990_CR22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1593\/neo.12346","volume":"14","author":"AS Fung","year":"2012","unstructured":"Fung AS, Jonkman J, Tannock IF (2012) Quantitative immunohistochemistry for evaluating the distribution of Ki67 and other biomarkers in tumor sections and use of the method to study repopulation in xenografts after treatment with paclitaxel. Neoplasia 14:324\u2013334","journal-title":"Neoplasia"},{"key":"2990_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humpath.2012.05.009","volume":"44","author":"W Huang","year":"2013","unstructured":"Huang W, Hennrick K, Drew S (2013) A colorful future of quantitative pathology: validation of Vectra technology using chromogenic multiplexed immunohistochemistry and prostate tissue microarrays. Hum Pathol 44:29\u201338. doi: 10.1016\/j.humpath.2012.05.009","journal-title":"Hum Pathol"},{"key":"2990_CR24","author":"M Klapczynski","year":"2012","unstructured":"Klapczynski M, Gagne GD, Morgan SJ, Larson KJ, Leroy BE, Blomme EA, Cox BF, Shek EW (2012) Computer-assisted imaging algorithms facilitate histomorphometric quantification of kidney damage in rodent renal failure models. J Pathol Inform. doi: 10.4103\/2153-3539.95456","journal-title":"J Pathol Inform"},{"key":"2990_CR25","author":"A Laurinavicius","year":"2012","unstructured":"Laurinavicius A, Laurinaviciene A, Ostapenko V, Dasevicius D, Jarmalaite S, Lazutka J (2012) Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data. Diagn Pathol. doi: 10.1186\/1746-1596-7-27","journal-title":"Diagn Pathol"},{"key":"2990_CR26","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1124\/dmd.110.034991","volume":"39","author":"J Konig","year":"2011","unstructured":"Konig J, Glaeser H, Keiser M, Mandery K, Klotz U, Fromm MF (2011) Role of organic anion-transporting polypeptides for cellular mesalazine (5-aminosalicylic acid) uptake. Drug Metab Dispos 39:1097\u20131102. doi: 10.1124\/dmd.110.034991","journal-title":"Drug Metab Dispos"},{"key":"2990_CR27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1124\/jpet.102.043026","volume":"304","author":"RG Tirona","year":"2003","unstructured":"Tirona RG, Leake BF, Wolkoff AW, Kim RB (2003) Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation. J Pharmacol Exp Ther 304:223\u2013228. doi: 10.1124\/102.043026","journal-title":"J Pharmacol Exp Ther"},{"key":"2990_CR28","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1124\/dmd.104.003244","volume":"33","author":"P Sandhu","year":"2005","unstructured":"Sandhu P, Lee W, Xu X, Leake BF, Yamazaki M, Stone JA, Lin JH, Pearson PG, Kim RB (2005) Hepatic uptake of the novel antifungal agent caspofungin. Drug Metab Dispos 33:676\u2013682. doi: 10.1124\/dmd.104.003244","journal-title":"Drug Metab Dispos"},{"key":"2990_CR29","author":"O Kis","year":"2012","unstructured":"Kis O, Zastre JA, Hoque MT, Walmsley SL, Bendayan R (2012) Role of drug efflux and uptake transporters in atazanavir intestinal permeability and drug\u2013drug interactions. Pharm Res. doi: 10.1007\/s11095-012-0942","journal-title":"Pharm Res"},{"key":"2990_CR30","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1124\/mol.109.059410","volume":"77","author":"PT Ronaldson","year":"2010","unstructured":"Ronaldson PT, Ashraf T, Bendayan R (2010) Regulation of multidrug resistance protein 1 by tumor necrosis factor alpha in cultured glial cells: involvement of nuclear factor-kappaB and c-Jun N-terminal kinase signaling pathways. Mol Pharmacol 77:644\u2013659","journal-title":"Mol Pharmacol"},{"key":"2990_CR31","first-page":"1517","volume":"28","author":"A Purohit","year":"2008","unstructured":"Purohit A, Chander SK, Woo LW, Parsons MF, Jhalli R, Potter BV, Reed MJ (2008) Inhibition of steroid sulphatase activity via the percutaneous route: a new option for breast cancer therapy. Anticancer Res 28:1517\u20131523","journal-title":"Anticancer Res"},{"key":"2990_CR32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0960-0760(03)00357-1","volume":"86","author":"T Nakata","year":"2003","unstructured":"Nakata T, Takashima S, Shiotsu Y, Murakata C, Ishida H, Akinaga S, Li PK, Sasano H, Suzuki T, Saeki T (2003) Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients. J Steroid Biochem Mol Biol 86:455\u2013460","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2990_CR33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0960-0760(03)00356-X","volume":"86","author":"T Suzuki","year":"2003","unstructured":"Suzuki T, Miki Y, Nakata T, Shiotsu Y, Akinaga S, Inoue K, Ishida T, Kimura M, Moriya T, Sasano H (2003) Steroid sulfatase and estrogen sulfotransferase in normal human tissue and breast carcinoma. J Steroid Biochem Mol Biol 86:449\u2013454","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2990_CR34","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1158\/0008-5472.CAN-05-1894","volume":"65","author":"Y Imai","year":"2005","unstructured":"Imai Y, Ishikawa E, Asada S, Sugimoto Y (2005) Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein\/ABCG2. Cancer Res 65:596\u2013604","journal-title":"Cancer Res"},{"key":"2990_CR35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1349-7006.2002.tb02162.x","volume":"93","author":"Y Imai","year":"2002","unstructured":"Imai Y, Tsukahara S, Ishikawa E, Tsuruo T, Sugimoto Y (2002) Estrone and 17beta-estradiol reverse breast cancer resistance protein-mediated multidrug resistance. Jpn J Cancer Res 93:231\u2013235","journal-title":"Jpn J Cancer Res"},{"key":"2990_CR36","author":"M Filipits","year":"2005","unstructured":"Filipits M, Pohl G, Rudas M, Dietze O, Lax S, Grill R, Pirker R, Zielinski CC, Hausmaninger H, Kubista E, Samonigg H, Jakesz R (2005) Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol. doi: 10.1200\/JCO.2005.03.033","journal-title":"J Clin Oncol"},{"key":"2990_CR37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1023\/A:1025751631115","volume":"81","author":"M Rudas","year":"2003","unstructured":"Rudas M, Filipits M, Taucher S, Stranzl T, Steger GG, Jakesz R, Pirker R, Pohl G (2003) Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy. Breast Cancer Res Treat 81:149\u2013157. doi: 10.1023\/1025751631115","journal-title":"Breast Cancer Res Treat"},{"key":"2990_CR38","doi-asserted-by":"crossref","first-page":"e64069","DOI":"10.1371\/journal.pone.0064069","volume":"8","author":"N Banerjee","year":"2013","unstructured":"Banerjee N, Fonge H, Mikhail A, Reilly RM, Bendayan R, Allen C (2013) Estrone-3-sulphate, a potential novel ligand for targeting breast cancers. PLoS One 8:e64069. doi: 10.1371\/0064069","journal-title":"PLoS One"},{"key":"2990_CR39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jsbmb.2010.06.014","volume":"122","author":"T Maeda","year":"2010","unstructured":"Maeda T, Irokawa M, Arakawa H, Kuraoka E, Nozawa T, Tateoka R, Itoh Y, Nakanishi T, Tamai I (2010) Uptake transporter organic anion transporting polypeptide 1B3 contributes to the growth of estrogen-dependent breast cancer. J Steroid Biochem Mol Biol 122:180\u2013185. doi: 10.1016\/j.jsbmb.2010.06.014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2990_CR40","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1124\/jpet.104.071522","volume":"311","author":"T Nozawa","year":"2004","unstructured":"Nozawa T, Suzuki M, Takahashi K, Yabuuchi H, Maeda T, Tsuji A, Tamai I (2004) Involvement of estrone-3-sulfate transporters in proliferation of hormone-dependent breast cancer cells. J Pharmacol Exp Ther 311:1032\u20131037. doi: 10.1124\/104.071522","journal-title":"J Pharmacol Exp Ther"},{"key":"2990_CR41","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1007\/s11095-005-7096-0","volume":"22","author":"T Nozawa","year":"2005","unstructured":"Nozawa T, Suzuki M, Yabuuchi H, Irokawa M, Tsuji A, Tamai I (2005) Suppression of cell proliferation by inhibition of estrone-3-sulfate transporter in estrogen-dependent breast cancer cells. Pharm Res 22:1634\u20131641. doi: 10.1007\/s11095-005-7096-0","journal-title":"Pharm Res"},{"issue":"1450\u20131455","key":"2990_CR42","first-page":"6282","volume":"7","author":"K Wlcek","year":"2008","unstructured":"Wlcek K, Svoboda M, Thalhammer T, Sellner F, Krupitza G, Jaeger W (2008) Altered expression of organic anion transporter polypeptide (OATP) genes in human breast carcinoma. Cancer Biol Ther 7(1450\u20131455):6282","journal-title":"Cancer Biol Ther"},{"key":"2990_CR43","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jsbmb.2008.12.008","volume":"113","author":"M Suzuki","year":"2009","unstructured":"Suzuki M, Ishida H, Shiotsu Y, Nakata T, Akinaga S, Takashima S, Utsumi T, Saeki T, Harada N (2009) Expression level of enzymes related to in situ estrogen synthesis and clinicopathological parameters in breast cancer patients. J Steroid Biochem Mol Biol 113:195\u2013201. doi: 10.1016\/j.jsbmb.2008.12.008","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2990_CR44","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-0-387-69080-3_19","volume":"617","author":"A Howell","year":"2008","unstructured":"Howell A, Bundred NJ, Cuzick J, Allred DC, Clarke R (2008) Response and resistance to the endocrine prevention of breast cancer. Adv Exp Med Biol 617:201\u2013211. doi: 10.1007\/978-0-387-69080-3_19","journal-title":"Adv Exp Med Biol"},{"issue":"Suppl 1","key":"2990_CR45","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s10549-005-9036-4","volume":"93","author":"RI Nicholson","year":"2005","unstructured":"Nicholson RI, Johnston SR (2005) Endocrine therapy\u2014current benefits and limitations. Breast Cancer Res Treat 93(Suppl 1):S3\u2013S10. doi: 10.1007\/s10549-005-9036-4","journal-title":"Breast Cancer Res Treat"},{"key":"2990_CR46","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/092986711794480177","volume":"18","author":"F Lumachi","year":"2011","unstructured":"Lumachi F, Luisetto G, Basso SM, Basso U, Brunello A, Camozzi V (2011) Endocrine therapy of breast cancer. Curr Med Chem 18:513\u2013522","journal-title":"Curr Med Chem"},{"key":"2990_CR47","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2174\/092986713804999303","volume":"20","author":"F Lumachi","year":"2013","unstructured":"Lumachi F, Brunello A, Maruzzo M, Basso U, Basso SM (2013) Treatment of estrogen receptor-positive breast cancer. Curr Med Chem 20:596\u2013604","journal-title":"Curr Med Chem"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-2990-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-014-2990-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-014-2990-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:47:31Z","timestamp":1559220451000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-014-2990-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,16]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["2990"],"URL":"https:\/\/doi.org\/10.1007\/s10549-014-2990-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,16]]}}}